Potentiating effects of combined usage of three sulfonylurea drugs on the occurrence of alloxan diabetes in rats.
Katsumata
K
K
Katsumata Hospital, Nagoya, Japan.
Katsumata
Y
Y
Ozawa
T
T
Katsumata
K
K
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy*; D004338:Drug Combinations; D004357:Drug Synergism; D005907:Gliclazide / Q000008:administration & dosage / Q000627:therapeutic use; D005905:Glyburide / Q000008:administration & dosage / Q000627:therapeutic use; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D014044:Tolbutamide / Q000008:administration & dosage / Q000627:therapeutic use
D001786:Blood Glucose; D004338:Drug Combinations; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D005907:Gliclazide; D005905:Glyburide